1.PTPRD demethylation regulates the proliferation, migration, and chemoresistance of gastric cancer cells through the PI3K/Akt/mTOR pathway
LIU Yanhuia,b ; GAO Ziyua ; REN Pengb ; DU Yuxinb ; LIU Caixiaa ; XING Zhiweia
Chinese Journal of Cancer Biotherapy 2025;32(1):48-55
[摘 要] 目的:探究蛋白酪氨酸磷酸酶D(PTPRD)去甲基化通过PI3K/Akt/mTOR通路对胃癌细胞增殖、迁移及化疗耐药性的影响。方法:体外培养胃癌细胞MKN-74、MKN-45和人胃黏膜上皮细胞GES-1并检测PTPRD表达。常规培养MKN-45细胞及耐药MKN-45/5-FU细胞,分别转染PTPRD空载体(NC组、NC/5-FU组)、PTPRD过表达腺病毒(PTPRD组、PTPRD/5-FU组)、shRNA空载体(sh-NC组、sh-NC/5-FU组)、shRNA-PTPRD慢病毒(sh-PTPRD组、sh-PTPRD/5-FU组)和PTPRD过表达腺病毒 + 10 μmol/L 740Y-P处理(PTPRD + 740Y-P组、PTPRD + 740Y-P/5-FU组)。MTT法、划痕愈合实验检测各组细胞的增殖活力和迁移能力,细胞自噬实验检测细胞的自噬水平,WB法检测细胞中EMT和PI3K/Akt/mTOR通路相关蛋白的表达。采用0、2.5、5、10、20、40 μmol/L的5-aza处理MKN-45细胞,qPCR法、MTT法检测细胞中PTPRD mRNA表达和细胞增殖活力。结果:PTPRD mRNA和蛋白在胃癌细胞中均呈低表达(P < 0.05)。与MKN-45组相比,PTPRD组自噬体与自噬溶酶体数量、PTPRD、上皮钙黏素(E-cadherin)、BAX蛋白表达均增加(均P < 0.05),细胞增殖活力、细胞迁移率、p-PI3K、波形蛋白(vimentin)、p-Akt、p-mTOR蛋白表达均降低(均P < 0.05),sh-PTPRD组细胞增殖活力、细胞迁移率、p-PI3K、vimentin、p-Akt、p-mTOR蛋白表达均增加(均P < 0.05),自噬体与自噬溶酶体数量、PTPRD、E-cadherin、BAX蛋白表达均减少(均P < 0.05);与PTPRD组相比,PTPRD + 740Y-P组细胞增殖活力、细胞迁移率、p-PI3K、vimentin、p-Akt、p-mTOR蛋白表达均增加(均P < 0.05),自噬体与自噬溶酶体数量、PTPRD、E-cadherin、BAX蛋白表达减少(均P < 0.05)。随着5-aza浓度的增加,MKN-45细胞中PTPRD mRNA表达增加、细胞增殖活力均降低(均P < 0.05)。与MKN-45/5-FU组相比,PTPRD/5-FU组细胞迁移率、细胞增殖活力均降低(均P < 0.05),sh-PTPRD/5-FU组细胞迁移率、细胞增殖活力均增加(均P < 0.05);与PTPRD/5-FU组相比,PTPRD + 740Y-P/5-FU组细胞迁移率、细胞增殖活力均增加(均P < 0.05)。结论:PTPRD在胃癌细胞中呈低表达状态,PTPRD去甲基化可能通过抑制PI3K/Akt/mTOR信号通路抑制胃癌细胞增殖、迁移并增强其对化疗的敏感性。
2.Model-based comparative prediction of transcription-factor binding motifs in anabolic responses in bone.
Andy B CHEN ; Kazunori HAMAMURA ; Guohua WANG ; Weirong XING ; Subburaman MOHAN ; Hiroki YOKOTA ; Yunlong LIU
Genomics, Proteomics & Bioinformatics 2007;5(3-4):158-165
Understanding the regulatory mechanism that controls the alteration of global gene expression patterns continues to be a challenging task in computational biology. We previously developed an ant algorithm, a biologically-inspired computational technique for microarray data, and predicted putative transcription-factor binding motifs (TFBMs) through mimicking interactive behaviors of natural ants. Here we extended the algorithm into a set of web-based software, Ant Modeler, and applied it to investigate the transcriptional mechanism underlying bone formation. Mechanical loading and administration of bone morphogenic proteins (BMPs) are two known treatments to strengthen bone. We addressed a question: Is there any TFBM that stimulates both "anabolic responses of mechanical loading" and "BMP-mediated osteogenic signaling"? Although there is no significant overlap among genes in the two responses, a comparative model-based analysis suggests that the two independent osteogenic processes employ common TFBMs, such as a stress responsive element and a motif for peroxisome proliferator-activated receptor (PPAR). The post-modeling in vitro analysis using mouse osteoblast cells supported involvements of the predicted TFBMs such as PPAR, Ikaros 3, and LMO2 in response to mechanical loading. Taken together, the results would be useful to derive a set of testable hypotheses and examine the role of specific regulators in complex transcriptional control of bone formation.
Algorithms
;
Animals
;
Base Sequence
;
Binding Sites
;
genetics
;
Biomechanical Phenomena
;
Bone Morphogenetic Proteins
;
pharmacology
;
Consensus Sequence
;
DNA
;
genetics
;
metabolism
;
Databases, Genetic
;
Gene Expression Profiling
;
statistics & numerical data
;
Genomics
;
statistics & numerical data
;
Mice
;
Oligonucleotide Array Sequence Analysis
;
statistics & numerical data
;
Osteoblasts
;
drug effects
;
metabolism
;
Osteogenesis
;
drug effects
;
genetics
;
physiology
;
Transcription Factors
;
metabolism
3.Direct Differentiation of Adult Ocular Progenitors into Striatal Dopaminergic Neurons.
Iqbal AHMAD ; Xing ZHAO ; Sowmya PARAMESWARAN ; Christopher J DESTACHE ; Jorge RODRIGUEZ-SIERRA ; Wallace B THORESON ; Hiba AHMAD ; John SORRENTINO ; Sudha BALASUBRAMANIAN
International Journal of Stem Cells 2015;8(1):106-114
Parkinson's disease, characterized by motor dysfunction due to the loss of nigrostriatal dopaminergic neurons, is one of the most prevalent age-related neurodegenerative disorders. Given there is no current cure, the stem cell approach has emerged as a viable therapeutic option to replace the dopaminergic neurons that are progressively lost to the disease. The success of the approach is likely to depend upon accessible, renewable, immune compatible, and non-tumorigenic sources of neural progenitors from which stable dopaminergic neurons can be generated efficaciously. Here, we demonstrate that neural progenitors derived from limbus, a regenerative and accessible ocular tissue, represent a safe source of dopaminergic neurons. When the limbus-derived neural progenitors were subjected to a well-established protocol of directed differentiation under the influence of Shh and FGF8, they acquired the biochemical and functional phenotype of dopaminergic neurons that included the ability to synthesize dopamine. Their intrastriatal transplantation in the rat model of hemi-Parkinsonism was associated with a reduction in the amphetamine-induced rotation. No tumor formation was observed 6 weeks post-transplantation. Together, these observations posit limbus-derived neural progenitors as an accessible and safe source of dopaminergic neurons for a potential autologous ex-vivo stem cell approach to Parkinson's disease.
Adult*
;
Dopamine
;
Dopaminergic Neurons*
;
Humans
;
Models, Animal
;
Neurodegenerative Diseases
;
Parkinson Disease
;
Phenotype
;
Stem Cells
4.Progression of diabetic retinopathy: the Beijing Eye Study.
Ying TU ; Liang XU ; Wen-Bin WEI ; Shuang WANG ; Ya-Xing WANG ; Jost B JONAS
Chinese Medical Journal 2011;124(22):3635-3640
<b>BACKGROUNDb>Diabetic retinopathy (DR) has emerged as a leading cause of visual impairment and blindness in the working-aged population worldwide. This study aimed to assess frequency and associated factors of progression of DR in subjects with known diabetes in a population-based setting.
<b>METHODSb>The Beijing Eye Study is a population based study performed in Greater Beijing in 2001 and 2006. The present investigation included all subjects with known diabetes mellitus in 2001, who participated in the follow-up examination in 2006. Fundus photographs were assessed.
<b>RESULTSb>The study included 170 subjects; 51 (30%) subjects showed signs of DR in 2001 and were re-examined in 2006, 36 (21.2%) subjects (18 subjects with DR present at baseline, 18 subjects with newly diagnosed DR in 2006) showed a progression of DR during follow-up. Progression of DR was associated with rural region (odds ratio (OR): 5.43, P = 0.001) and self-reported arterial hypertension (OR: 3.85, P = 0.023). In the non-progressive subgroup, presence of DR was associated with different levels of education (< middle school, middle school, college or higher, OR: 0.30, P = 0.023), treatment modes of diabetes mellitus (OR: 10.24, P = 0.003) and cataract surgery (OR: 9.14, P = 0.007).
<b>CONCLUSIONSb>In a population-based setting in Greater Beijing, progression of DR occurred in 35% of subjects with pre-existing DR and overall in 21% of subjects with known diabetes within a 5-year period. Progression of DR was significantly associated with rural region and self-reported arterial hypertension. In the stable subjects, presence of DR was significantly associated with poor educational level, insulin treatment of diabetes and cataract surgery.
Adult ; Aged ; Aged, 80 and over ; China ; Diabetes Mellitus ; drug therapy ; physiopathology ; Diabetic Retinopathy ; epidemiology ; pathology ; Female ; Humans ; Hypertension ; physiopathology ; Insulin ; therapeutic use ; Male ; Middle Aged ; Multivariate Analysis
5.Bone marrow mesenchymal stem cell derived exosomes miR-21-5p promotes proliferation, migration and invasion of prostate cancer PC-3 cell by downregulating PHLPP2
KE Jingwei ; SHEN Hongchun ; LIU Xing ; JI Meiying ; TANG Yiquan
Chinese Journal of Cancer Biotherapy 2020;27(5):534-540
[Abstract] Objective: To investigate the effects of exosome originated from bone marrow mesenchymal stem cell (BMSCs) on proliferation, migration and invasion of prostate cancer PC-3 cell and its mechanism. Methods: qPCR was used to detect the expression level of miR-21-5p in prostate cancer cell lines. The morphology of exosomes isolated from BMSCs was observed with an electron microscope. Western blotting was used to detect the expressions of exosome surface markers and the epithelial-mesenchymal transition (EMT)-related proteins (E-cadherin, N-cadherin and Vimentin). Dual luciferase reporter gene experiment was used to detect the targeted regulation relationship between miR-21-5p and PH domain leucine-rich repeat protein phosphatase 2 (PHLPP2). PC-3 cells were co-cultured with 10 μl BMSCs exosomes suspension (Exo group), transfected with sh-PHLPP2 or antagomiR, then CCK-8 and Transwell experiments were used to detect changesinproliferation,migrationandinvasionofPC-3cell.Results: miR-21-5p was highly expressed in prostate cancer PC-3 cell line. The exosomes in the supernatant of BMSCs culture fluid were successfully isolated, and the typical vesicle-like structures of exosomes were observed under transmission electron microscope. Exosomes expressed specific proteins such as CD9, CD63 and CD81. In the Exo group, the proliferation, invasion, migration, as well as the expressions of N-cadherin, Vimentin and miR-21-5p in PC-3 cells were significantly higher than those in the control group (all P<0.05). PHLPP2 is a target gene of miR-21-5p. Compared with the control group, the expression of PHLPP2 in PC-3 cells of Exo group and sh-PHLPP2 group was significantly reduced (0.66±0.09, 0.42±0.05 vs 1.09±0.08, all P<0.01); cell viability, invasion and migration were significantly improved (all P<0.01); and E-cadherin expression level was significantly reduced while N-cadherin and Vimentin expressions were significantly increased (both P<0.05). Conclusion: miR-21-5p is highly expressed in prostate cancer PC-3 cell line. BMSC exosome miR-21-5p can increase the proliferation, migration and invasion ability of PC-3 cells through targeted down-regulation of PHLPP2.
6.Model-based Comparative Prediction of Transcription-Factor Binding Motifs in Anabolic Responses in Bone
Chen B. ANDY ; Hamamura KAZUNORI ; Wang GUOHUA ; Xing WEIRONG ; Mohan SUBBURAMAN ; Yokota HIROKI ; Liu YUNLONG
Genomics, Proteomics & Bioinformatics 2007;2(3):158-165
Understanding the regulatory mechanism that controls the alteration of global gene expression patterns continues to be a challenging task in computational biology. We previously developed an ant algorithm, a biologically-inspired computational technique for microarray data, and predicted putative transcription-factor binding motifs (TFBMs) through mimicking interactive behaviors of natural ants. Here we extended the algorithm into a set of web-based software, Ant Modeler, and applied it to investigate the transcriptional mechanism underlying bone formation. Mechanical loading and administration of bone morphogenic proteins (BMPs) are two known treatments to strengthen bone. We addressed a question: Is there any TFBM that stimulates both "anabolic responses of mechanical loading" and "BMP-mediated osteogenic signaling"? Although there is no significant overlap among genes in the two responses, a comparative model-based analysis suggests that the two independent osteogenic processes employ common TFBMs, such as a stress responsive element and a motif for peroxisome proliferator-activated recep- tor (PPAR). The post-modeling in vitro analysis using mouse osteoblast cells sup- ported involvements of the predicted TFBMs such as PPAR, Ikaros 3, and LMO2 in response to mechanical loading. Taken together, the results would be useful to derive a set of testable hypotheses and examine the role of specific regulators in complex transcriptional control of bone formation.
7.In vitro construction and amplification and primary functional analysis of antiCD19 chimeric antigen receptor(CD19-CAR) modifiedTcells
LI Jian ; TIAN Fang ; JIANG Pengjun ; KONG Xiangtu ; WU Jian ; YIN Tingting ; XING Yun ; JIN Liang ; HAO Ruidong ; LIU Gentao ; ZHU Xuejun
Chinese Journal of Cancer Biotherapy 2018;25(4):389-393
[Abstract] Objective: To establish a chimeric antigen receptor(CAR)modified T cells specifically targeting CD19 molecule (CD19CAR-T cells) and to testify their in vitro killing effect on target cells. Methods: CD19-CAR fragments yielded by PCR were constructed into pCDH-GFP lentiviral vectors by molecular cloning technology. The packaged lentiviral particles were transducted into CD3+ T cells of donors. Transduction efficiency was measured by flow cytometry and PCR. The in vitro cytotoxicity of obtained CD19CAR-T cells against CD19+ Ramos cells was tested by 7-AAD staining. Results: The amplification folds of CD3+ T cells increased to (78.8± 23.2) folds after in vitro culture for 10 days, and about (58.3±5.4)% cells expressing GFP.About (57.4±9.3)% CD19+Ramos cells were specifically killed by the CD19-CAR-T cells in vitro at the E∶T ratio of 5∶1. Conclusion: This study successfully established an effective method for constructing and amplifying CD19-CAR-T cells in vitro, which showed profound efficiency and specific cytotoxity against CD19+ Ramos cells.And this report might provide an experimental evidence for clinical treatment of CD19+ B cell neoplasmas.
8.Establishment and observation of a mouse model of IL-12-CAR-T cell-induced cytokine release syndrome
LI Chencheng1 ; LIU Xixi1 ; CHEN Biqing2a ; TIAN Fang2a ; ZHANG Weiguang1 ; YANG Jing1 ; REN Jiangtao3 ; XING Yun3 ; ZHU Xuejun1,2b
Chinese Journal of Cancer Biotherapy 2023;30(1):28-34
[摘 要] 目的:通过构建表达IL-12的小鼠CAR-T细胞,探讨经尾静脉将其输注于小鼠体内建立细胞因子释放综合征(CRS)模型的方法。方法:构建基于靶向鼠源CD19的CAR分子,包装逆转录病毒载体并感染小鼠T细胞构建mCD19-CAR-T、mCD19/IL-12-CAR-T细胞。通过构建小鼠体内胰腺癌Panc02-CD19细胞移植瘤模型,检测mCD19/IL-12-CAR-T细胞的抗肿瘤活性,ELISA法检测两种CAR-T细胞IL-12和IFN-γ分泌水平;经小鼠尾静脉输注mCD19/IL-12-CAR-T 细胞构建CAR-T细胞CRS小鼠模型,流式细胞术检测小鼠血清中IL-6、MCP-1、IL-1、IL-10、TNF-α、IFN-γ等细胞因子的含量,H-E染色法观察荷瘤小鼠肝、脾、肺和肾的病理组织学变化。结果:经过培养扩增的mCD19/IL-12-CAR-T细胞能有效分泌IL-12,CAR阳性率达(56.9±5.4)%;与非靶细胞Panc02或靶细胞Panc02-CD19共培养时,均能高分泌IFN-γ。成功构建小鼠胰腺癌Panc02-CD19细胞移植瘤模型,经小鼠尾静脉注射1×106个mCD19/IL-12-CAR-T细胞能显著抑制移植瘤的生长,但未能诱发严重CRS;输注2×106个mCD19/IL-12-CAR-T细胞后,小鼠出现体质量减轻、血清炎性因子水平升高、组织损伤,最终导致死亡等一系列典型CRS表现。结论:成功构建IL-12-CAR-T细胞诱发的小鼠CRS模型,其稳定性好、重复性高,具有广泛的应用前景。
9.Recommendations for the use of the acetaminophen hepatotoxicity model for mechanistic studies and how to avoid common pitfalls.
Hartmut JAESCHKE ; Olamide B ADELUSI ; Jephte Y AKAKPO ; Nga T NGUYEN ; Giselle SANCHEZ-GUERRERO ; David S UMBAUGH ; Wen-Xing DING ; Anup RAMACHANDRAN
Acta Pharmaceutica Sinica B 2021;11(12):3740-3755
Acetaminophen (APAP) is a widely used analgesic and antipyretic drug, which is safe at therapeutic doses but can cause severe liver injury and even liver failure after overdoses. The mouse model of APAP hepatotoxicity recapitulates closely the human pathophysiology. As a result, this clinically relevant model is frequently used to study mechanisms of drug-induced liver injury and even more so to test potential therapeutic interventions. However, the complexity of the model requires a thorough understanding of the pathophysiology to obtain valid results and mechanistic information that is translatable to the clinic. However, many studies using this model are flawed, which jeopardizes the scientific and clinical relevance. The purpose of this review is to provide a framework of the model where mechanistically sound and clinically relevant data can be obtained. The discussion provides insight into the injury mechanisms and how to study it including the critical roles of drug metabolism, mitochondrial dysfunction, necrotic cell death, autophagy and the sterile inflammatory response. In addition, the most frequently made mistakes when using this model are discussed. Thus, considering these recommendations when studying APAP hepatotoxicity will facilitate the discovery of more clinically relevant interventions.
10.Study on the distribution of ABO blood group in patients with pancreatic cancer
Xiaoliang YANG ; Xiaoqin ZHOU ; Jing LI ; Xia ZHONG ; Kun WANG ; Xiaoyan TANG ; Xing GU
Chinese Journal of Blood Transfusion 2023;36(2):152-155
【Objective】 To investigate whether there is a correlation between the differences in ABO blood group distribution in patients with pancreatic cancer, and to evaluate the relative risk. 【Methods】 Patients with pathological diagnosis or discharge diagnosis of pancreatic cancer who underwent ABO blood group typing in our hospital from January 2017 to October 2021 were selected, and the blood group distribution of patients and the correlation were analyzed. 【Results】 There was a statistically significant difference between the pancreatic cancer group and the control group (P<0.05). The study showed that type A may be a relative risk factor for pancreatic cancer patients (χ2=42.44, P<0.001), and type B may play a protective role (χ2=16.28, P<0.01). Significant differences were found in distribution between different gender groups (χ2=64.35, P<0.05). The test results showed that type A may be a risk factor for pancreatic cancer in men (χ2=35.2, OR=1.7, 95%CI=0.59-1.02, P<0.001), and type O may play a protective role in pancreatic cancer(χ2=18.22, OR=0.6, 95%CI=0.25-0.32, P<0.01); type A may be a relative risk factor for female pancreatic cancer patients (χ2=7.06, OR=1.4, 95%CI=0.59-1.02, P<0.001), while type B may play a protective role (χ2=20.32, OR=0.5, 95%CI=0.32-0.43, P<0.01). In pancreatic cancer group, the risk factors of blood type A were higher than those of non-A group, and the protective effect of type B was significantly higher than that of non-B group. 【Conclusion】 The distribution of blood group and relative risk factors in pancreatic cancer patients suggest that A type is predominant; in the population with A blood group, more attention should be paid to early prevention and early treatment, so as to reduce the risk of disease.